AAPG
Ascentage Pharma Group International Co., Ltd.
NASDAQ · Healthcare · Biotechnology · CN
$15.06
−2.02%Margins
Gross margin
81.6%
EBITDA margin
-205.4%
EBIT margin
-218.8%
Net margin
-228.7%
FCF margin
-221.1%
-260.1%
Return on equity
-44.7%
Return on assets
-52.2%
Return on invested capital
0.18x
Asset turnover
-$205.6M
Cash from operations
$3.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026